Cancer Vaccines: Technologies and Global Markets

July 2021 | 155 pages | ID: C23D2F1C0D4EN
BCC Research

Abstracts

Report Scope:

The scope of this study involves the global market of cancer vaccines. The report covers the entire market of cancer vaccines, which includes two main areas of application, prophylactic vaccines and therapeutic vaccines. Discussion of human papillomavirus vaccines and hepatitis B vaccines that indirectly act against cancer is also included in the report.

Based on application, the market covers various cancer types such as prostate, liver, cervical, lung and bladder. Both marketing and research and development (R&D) perspectives are discussed in the report.

By geography, the market has been divided into four regions: North America, Europe, Asia-Pacific and Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data have been provided for the year 2020 as the base year, with forecasts for 2021 through 2026.

Patent analysis, clinical trials, innovative research and opportunities of the newest trends within the cancer vaccine market and comprehensive profiles of companies that lead the cancer vaccine industry are also discussed.

Report Includes:

• 20 data tables and 23 additional tables
• An overview of the global markets and technologies for cancer vaccines
• Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 with projections of compound annual growth rates (CAGRs) through 2026
• Detailed description of history, management, and causes of cancer including genetic factors, lifestyle factors and environmental factors, and information on types of cancer-causing genes
• Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast, and an overview of current and future dynamics of the global market for various cancer vaccines
• Discussion on present and future strategies within the cancer vaccines market, and comparative assessment of prophylactic vaccines and therapeutic vaccines
• Coverage of approved cancer vaccines, recalls, fast track designations and orphan drug designation and analysis of pipeline products and patents
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
• Comprehensive company profiles of the leading players of the industry, including Amgen Inc., Dendreon Corp., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Merck & Co. Inc. and Vaccinogen Inc.

Contents

CHAPTER 1 INTRODUCTION

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
What's New in This Report
Related BCC Research Reports

CHAPTER 2 SUMMARY AND HIGHLIGHTS

Market Size and Evolution

CHAPTER 3 MARKET OVERVIEW

Definition
History of Cancer and Its Management
Causes of Cancer
Genetic Factors
Lifestyle Factors
Environmental Factors
Types of Cancer-Causing Genes
Immune System and Cancer
Classification of Cancer
Cancer Prevention
Types of Cancer Treatment
Surgery
Radiation Therapy
Chemotherapy
Immunotherapy
Targeted Therapy
Hormone Therapy
Cancer Vaccines
Liver Cancer
Prostate Cancer
Cervical Cancer
Cancer Vaccines Platform
Tumor-Cell Vaccines
Cancer Stem Cell Vaccines
Peptide/Protein Vaccines

CHAPTER 4 IMPACT OF COVID-19 ON THE MARKET

Overview
Current Outlook
COVID-19 Impact on Cancer Care

CHAPTER 5 REGULATORY ASPECTS

Overview
Regulatory History of Approved Cancer Vaccines
Recalls
Orphan Drug Designation
Fast-Track Designations

CHAPTER 6 MARKET BREAKDOWN BY TYPE

Overview
Market Overview
Market Revenue
Therapeutic Vaccines
Market Overview
Market Revenue
Prophylactic Vaccines
Market Overview
Market Revenue

CHAPTER 7 MARKET BREAKDOWN BY APPLICATION

Overview
Cancer Vaccines Application in Various Cancers
Market Revenues
Prostate Cancer
Market Overview
Market Revenue
Liver Cancer
Market Overview
Market Revenue
Cervical Cancer
Market Overview
Market Revenue
Others
Market Overview
Market Revenue

CHAPTER 8 MARKET BREAKDOWN BY REGION

Introduction
North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World

CHAPTER 9 INDUSTRY STRUCTURE

Competitive Landscape
Patent Analysis
Pipeline Analysis
Prostate Cancer
Breast Cancer
Cervical Cancer
Liver Cancer
Lung Cancer
Stomach Cancer
Colorectal Cancer
Esophageal Cancer

CHAPTER 10 CURRENT SITUATION

Overview
Factors Affecting Cancer Vaccines
Increasing Prevalence of Cancer
Aging Population
Lifestyle Changes
Approvals for Additional Indications
Competition
Increased Funding
Manufacturers' Strategies
Challenges in Cancer Vaccines

CHAPTER 11 COMPANY PROFILES

AMGEN INC.
ANIXA BIOSCIENCES INC.
DENDREON CORP.
ETHERNA
F. HOFFMANN-LA ROCHE LTD.
GLAXOSMITHKLINE PLC
IMMUNICUM AB
INOVIO PHARMACEUTICALS INC.
MERCK & CO. INC.
MODERNA INC.
OSE IMMUNOTHERAPEUTICS
PROVIDENCE THERAPEUTICS HOLDINGS INC.
UBIVAC
VACCINOGEN INC.

CHAPTER 12 OTHER INTERNATIONAL COMPANIES

ADAMIS PHARMACEUTICALS CORP.
ADVAXIS INC.
ALPHAVAX INC.
BELLICUM PHARMACEUTICALS INC.
CANDEL THERAPEUTICS INC.
CELLDEX THERAPEUTICS INC.
CUREVAC AG
GENEXINE INC.
GLOBEIMMUNE INC.
GRADALIS INC.
IMMUNOVATIVE THERAPIES LTD.
ISA PHARMACEUTICALS B.V.
ONCOVIR INC.
SOTIO A.S.
VAXON BIOTECH

CHAPTER 13 APPENDIX A: ACRONYMS

List Of Tables

LIST OF TABLES

Summary Table A: Global Market for Cancer Vaccines, by Type, Through 2026
Summary Table B: Global Market for Cancer Vaccines, by Region, Through 2026
Table 1: History of Cancer and Its Management
Table 2: COVID-19 Reported Cases and Deaths, by Country
Table 3: Regulatory Approvals of Cancer Vaccines
Table 4: Product Recalls of Cancer Vaccines
Table 5: Significant Orphan Drug Designations Approved
Table 6: Global Market for Cancer Vaccines, by Type, Through 2026
Table 7: Global Market for Cancer Vaccines, by Application, Through 2026
Table 8: Global Market for Prostate Cancer Vaccines, by Region, Through 2026
Table 9: Global Market for Liver Cancer Vaccines, by Region, Through 2026
Table 10: Global Market for Cervical Cancer Vaccines, by Region, Through 2026
Table 11: Global Market for Other Cancer Vaccines, by Region, Through 2026
Table 12: Global Market for Cancer Vaccines, by Region, Through 2026
Table 13: North American Market for Cancer Vaccines, by Type, Through 2026
Table 14: North American Market for Cancer Vaccines, by Application, Through 2026
Table 15: North American Market for Cancer Vaccines, by Country, Through 2026
Table 16: European Market for Cancer Vaccines, by Type, Through 2026
Table 17: European Market for Cancer Vaccines, by Application, Through 2026
Table 18: European Market for Cancer Vaccines, by Country, Through 2026
Table 19: Asia-Pacific Market for Cancer Vaccines, by Type, Through 2026
Table 20: Asia-Pacific Market for Cancer Vaccines, by Application, Through 2026
Table 21: Asia-Pacific Market for Cancer Vaccines, by Country, Through 2026
Table 22: Rest of the World Market for Cancer Vaccines, by Type, Through 2026
Table 23: Rest of the World Market for Cancer Vaccines, by Application, Through 2026
Table 24: Leading Manufacturers of Cancer Vaccines, by Sales, 2020
Table 25: Patent Filed for Cancer Vaccines
Table 26: Significant Prostate Cancer Vaccines in Development
Table 27: Number of Clinical Trials on Prostate Cancer Vaccines
Table 28: Significant Breast Cancer Vaccines in Development
Table 29: Number of Clinical Trials on Breast Cancer Vaccines
Table 30: Significant Cervical Cancer Vaccines in Development
Table 31: Number of Clinical Trials on Cervical Cancer Vaccines
Table 32: Significant Liver Cancer Vaccines in Development
Table 33: Number of Clinical Trials on Liver Cancer Vaccines
Table 34: Significant Lung Cancer Vaccines in Development
Table 35: Number of Clinical Trials on Lung Cancer Vaccines
Table 36: Significant Stomach Cancer Vaccines in Development
Table 37: Number of Clinical Trials on Stomach Cancer Vaccines
Table 38: Significant Colorectal Cancer Vaccines in Development
Table 39: Number of Clinical Trials on Colorectal Cancer Vaccines
Table 40: Significant Esophageal Cancer Vaccines in Development
Table 41: Number of Clinical Trials on Esophageal Cancer Vaccines
Table 42: Abbreviations Used in This Report

List Of Figures

LIST OF FIGURES

Summary Figure A: Global Market Shares of Cancer Vaccines, by Application, 2020
Summary Figure B: Global Market for Cancer Vaccines, by Region, 2019–2026
Figure 1: Global Market Shares of Cancer Vaccines, by Type, 2020
Figure 2: Global Market for Therapeutic Vaccines, 2020–2026
Figure 3: Global Market for Therapeutic Vaccines, by Region, 2020–2026
Figure 4: Global Market for Prophylactic Vaccines, 2020–2026
Figure 5: Global Market for Prophylactic Vaccines, by Region, 2020–2026
Figure 6: Global Market Shares of Cancer Vaccines, by Application, 2020
Figure 7: Global Market for Prostate Cancer Vaccines, 2020–2026
Figure 8: Global Market for Prostate Cancer Vaccines, by Region, 2020–2026
Figure 9: Global Market for Liver Cancer Vaccines, 2020–2026
Figure 10: Global Market for Liver Cancer Vaccines, by Region, 2020–2026
Figure 11: Global Market for Cervical Cancer Vaccines, 2020–2026
Figure 12: Global Market for Cervical Cancer Vaccines, by Region, 2020–2026
Figure 13: Global Market for Other Cancer Vaccines, 2020–2026
Figure 14: Global Market for Other Cancer Vaccines, by Region, 2020–2026
Figure 15: Global Market for Cancer Vaccines, by Region, 2020–2026
Figure 16: North American Market Shares of Cancer Vaccines, by Type, 2020
Figure 17: North American Market Shares of Cancer Vaccines, by Application, 2020
Figure 18: North American Market Shares of Cancer Vaccines, by Country, 2020
Figure 19: U.S. Market for Cancer Vaccines, 2020–2026
Figure 20: Canadian Market for Cancer Vaccines, 2020–2026
Figure 21: European Market Shares of Cancer Vaccines, by Type, 2020
Figure 22: European Market Shares of Cancer Vaccines, by Application, 2020
Figure 23: European Market Shares for Cancer Vaccines, by Country, 2020
Figure 24: German Market for Cancer Vaccines, 2020–2026
Figure 25: U.K. Market for Cancer Vaccines, 2020–2026
Figure 26: French Market for Cancer Vaccines, 2020–2026
Figure 27: Italian Market for Cancer Vaccines, 2020–2026
Figure 28: Spanish Market for Cancer Vaccines, 2020–2026
Figure 29: Rest of European Market for Cancer Vaccines, 2020–2026
Figure 30: Asia-Pacific Market Shares of Cancer Vaccines, by Type, 2020
Figure 31: Asia-Pacific Market Shares of Cancer Vaccines, by Application, 2020
Figure 32: Asia-Pacific Market for Cancer Vaccines, by Country, 2020
Figure 33: Chinese Market for Cancer Vaccines, 2020–2026
Figure 34: Indian Market for Cancer Vaccines, 2020–2026
Figure 35: Japanese Market for Cancer Vaccines, 2020–2026
Figure 36: Rest of Asia-Pacific Market for Cancer Vaccines, 2020–2026
Figure 37: Rest of the World Market Shares of Cancer Vaccines, by Type, 2020
Figure 38: Rest of the World Market Shares of Cancer Vaccines, by Application, 2020
Figure 39: Global Manufacturers Market Shares of Cancer Vaccines, 2020